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Background: Human dental pulp represents a suitable alternative source of stem cells for the purpose of cell-based
therapies in regenerative medicine, because it is relatively easy to obtain it, using low invasive procedures. This study
characterized and compared two subpopulations of adult stem cells derived from human dental pulp (hDPSCs). Human
DPSCs, formerly immune-selected for STRO-1 and c-Kit, were separated for negativity and positivity to CD34 expression
respectively, and evaluated for cell proliferation, stemness maintenance, cell senescence and multipotency.
Results: The STRO-1+/c-Kit+/CD34+ hDPSCs showed a slower proliferation, gradual loss of stemness, early cell
senescence and apoptosis, compared to STRO-1+/c-Kit+/CD34− hDPSCs. Both the subpopulations demonstrated
similar abilities to differentiate towards mesoderm lineages, whereas a significant difference was observed after
the neurogenic induction, with a greater commitment of STRO-1+/c-Kit+/CD34+ hDPSCs. Moreover, undifferentiated
STRO-1+/c-Kit+/CD34− hDPSCs did not show any expression of CD271 and nestin, typical neural markers, while STRO-1
+/c-Kit+/CD34+ hDPSCs expressed both.
Conclusions: These results suggest that STRO-1+/c-Kit+/CD34− hDPSCs and STRO-1+/c-Kit+/CD34+ hDPSCs might
represent two distinct stem cell populations, with different properties. These results trigger further analyses to
deeply investigate the hypothesis that more than a single stem cell population resides within the dental pulp, to
better define the flexibility of application of hDPSCs in regenerative medicine.
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The stem cell field represents an area of particular inter-
est for scientific research. New therapeutic strategies
have been made possible, thanks to great advancements
in stem cell biology, with the aim to regenerate tissues
damaged by injuries or diseases [1,2]. Based on their
ability to rescue and/or repair injured tissue and partially
restore organ function, several types of stem/progenitor
cells have been investigated. Stem cells can be described
as undifferentiated cells that are characterized by three
fundamental abilities: proliferation, self-renewal, and* Correspondence: gianluca.carnevale@unimore.it
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unless otherwise stated.differentiation towards multiple cell lineages [3]. The dif-
ferentiation process can be recognized by a change in
cell morphology and by the expression of tissue-specific
proteins [4].
Adult stem cells have been identified in many organs
and tissues, including brain, bone marrow, peripheral
blood, blood vessels, skeletal muscle, skin, teeth, heart,
gut, liver, ovarian epithelium, and testis [5].
Among these tissues, dental pulp, a soft connective tis-
sue contained within the pulp chamber of the tooth, is
considered an interesting source of adult stem cells due
to the high content of cells and to the low-invasive pro-
cedures required for cell isolation, compared to other
adult tissue sources [6-8]. The first type of dental stem
cell was isolated from the human pulp tissue and termed
“postnatal dental pulp stem cells” (DPSCs) which arel. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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of dental-MSC-like populations were isolated and char-
acterized: stem cells from human exfoliated deciduous
teeth (SHEDs) [10], stem cells from apical papilla of
human immature permanent teeth (SCAPs) [11-13].
Moreover, DPSCs can be also isolated from supernumer-
ary teeth, which are generally discarded [13]. Other
sources of dental stem cells are the periodontal ligament,
which retains periodontal ligament stem cells (PDLSCs)
[14] and the dental follicle, containing dental follicle
progenitor cells (DFPCs) [15,16]. The typical surface
markers of mesenchymal stem cells are CD44, CD73,
CD90, CD105, CD271 and STRO-1, while the negative
markers are CD34, CD45, and HLA-DR [17]. However
there is no specific, strict marker characterizing DPSCs,
which are considered a heterogeneous population.
Indeed, different mesenchymal stem cell markers were
used to select different subsets of DPSCs displaying dif-
ferent biological behaviours [18]. STRO-1 which is con-
sidered a specific mesenchymal stem cells (MSC)
marker, in DPSCs was also demonstrated to identify a
subgroup of cells with odontogenic and osteogenic
properties [19]. Another isolated DPSCs population re-
vealed to be positive for CD34 and CD117 and negative
for CD45 [20]. Particularly, c-Kit, a membrane tyrosin-
kinase receptor, which specifically interacts with the
stem cell factor (SCF), is expressed by different cell
types. Its expression is well identified in melanocytes
[21], hematopoietic stem cells [22], adipose stem cells
[23] and bone marrow stem cells [24]. Moreover, Laino
et al. demonstrated that c-Kit expression was found in
human adult dental pulp stem cells [20].
Other markers expressed by DPSCs are CD29 and
CD44 [25], as well as CD73 and CD105 [26], all markers
of mesenchymal stemness. Several DPSCs clones were
established from CD271+ pulp cells; these CD271+ pulp
cells also express CD105 and Notch2 [27]. Interestingly,
CD271, one of two receptor types for the neurotro-
phins, a family of protein growth factors that stimulate
neuronal cells to survive, was reported to inhibit the
differentiation of mesenchymal stem cells, including
DPSCs, into osteogenic, adipogenic, chondrogenic, and
myogenic lineages [28].
DPSCs are also reported to express OCT4 and Nanog,
transcriptional factors involved in pluri/multipotency
maintenance [29]. Numerous studies have evaluated the
multipotency of DPSCs, which were demonstrated to be
able to differentiate in many cell types, such as osteo-
blasts, smooth muscle cells, adipocytes and neuronal-
like cells [30-34]. So far, no cloning based on single sur-
face marker has been capable of isolating cells that
match the minimal criteria of MSCs, from different tis-
sue environments. A variety of candidate MSC surface
antigens or markers likely related to their stemness havebeen proposed until now, nevertheless there is a huge
difference in their expression in distinct sources of
MSCs. As a matter of fact, the identity of MSCs in vivo
is still unclear, although reports have suggested they may
have a fibroblastic or pericytic origin [35,36].
This study was aimed to analyze and compare the char-
acteristics of two subpopulations of hDPSCs. Starting
from a first positive immune-selection for STRO-1 and c-
Kit (CD117) surface antigens, the sorted STRO-1+/c-Kit+
hDPSCs underwent a further immune-selection for CD34,
in order to separate and compare the STRO-1+/c-Kit
+/CD34− and STRO-1+/c-Kit+/CD34+ sub-fractions, in
terms of proliferation capacity, stemness maintenance,
multi-lineage differentiation potential, senescence and
apoptosis.
As described by Simmons and Torok-Storb [37], CD34
is a typical marker for primitive pluripotent stem cells,
both stromal and hematopoietic. Based on the “consen-
sus” extrapolated from the minimal criteria for definition
of MSCs, as proposed by The Mesenchymal and Tissue
Stem Cell Committee of the International Society for
Cellular Therapy [38] CD34 is assumed to be a negative
marker for MSCs. On the other hand, CD34 is a univer-
sally accepted hematopoietic stem cell (HSC) marker.
However, in 1996 Osawa et al. [39] reported the identifi-
cation of CD34 negative HSCs and that, despite being
CD34 negative, these cells remained capable of reconsti-
tuting the lymphohematopoietic system. Over the years,
extensive research reported the expression of CD34 also
by mesenchymal stem cells, obtained from different
sources, such as bone marrow mesenchymal stem cells
(BM-MSC) [37], adipose derived stem cells (ADSC) [40]
and DPSC [41]. According to findings from Laino et al.
[42], CD34 expression associated with c-Kit and STRO-1
expression could allow the identification of a niche of
hDPSCs derived from neural crest. Though, the function
of CD34 is still uncertain. Therefore, it is interesting to
isolate the two hDPSCs populations sorted and enriched
for STRO-1 and c-Kit expression, associated or not to
CD34 expression, and to compare the eventual differ-
ences between these two stem cell populations obtained
from the same individual.
On the basis of the combined expression of STRO-1,
c-Kit and CD34, the STRO-1+/c-Kit+/CD34+ hDPSCs
might represent a population of stromal stem cells of
neural crest origin. This hypothesis would be in accord-
ance with previous reports whereby head and neck hard
tissues of the body have been shown to have, other than
a mesodermal origin, a neural crest derivation [20,43].
From these investigations it was found that STRO-1+/
c-Kit+/CD34− hDPSCs and STRO-1+/c-Kit+/CD34+
hDPSCs actually are two different cell populations show-
ing distinct behaviors with regard to cell proliferation rate,
stemness maintenance and cell senescence/apoptosis
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performed in vitro towards mesoderm (osteogenic, adi-
pogenic, myogenic) and ectoderm (neurogenic) lineages
revealed the most evident differences between the two
hDPSCs populations; in particular, while no significant
differences between the two subpopulations have arisen
after differentiation towards the mesoderm lineages (osteo-
genic, adipogenic, myogenic), the STRO-1+/c-Kit+/CD34+
hDPSCs showed a stronger tendency towards the neurogenic
commitment, compared to the STRO-1+/c-Kit+/CD34−
hDPSCs. These data suggest that within dental pulp
actually more than a single stem cell population
may exist; indeed, stem cells obtained from dental
pulp may derive either from mesoderm either from
neuro-ectoderm [44,45]. The results obtained in this
study might trigger further analyses aimed to better
define the flexibility of application of dental pulp
derived stem cells for their use in therapeutic appli-
cations.
Methods
Cell isolation and sorting
Human dental pulp was extracted from the enclosed
third molar of teenage subjects undergoing a routine
tooth extraction, after written informed consent of their
parents (harvested specimen would be discarded any-
way). Cells were isolated from dental pulp as described
in a previous study [46]. Briefly, dental pulp was har-
vested from the teeth and immersed in a digestive solu-
tion (3 mg/mL type I collagenase plus 4 mg/mL dispase
in α-MEM) for 1 h at 37°C. After enzymatic disaggrega-
tion, pulp was dissociated and then filtered onto 100 μm
Falcon Cell Strainers, in order to obtain a cell suspen-
sion. Cell suspension was then plated in 25 cm2 flasks
and cultured in culture medium [α-MEM with 10% heat
inactivated foetal calf serum (FCS), 2 mM L-glutamine,
100 U/mL penicillin, 100 μg/mL streptomycin], at 37°C
and 5% CO2. At day 3–4 of culture, cells obtained from
the entire dental pulp were subsequently trypsinized, re-
suspended and plated at clonal density (1.6 cell/cm2). At
day 7, eight cell populations were isolated from colonies
originated by single cells. After isolation of formed colonies,
hDPSCs were expanded upon reaching 70% confluency and
about 5 × 106 cells were used for following magnetic cell
sorting (passage 2).
The STRO-1+/c-Kit+ hDPSCs were obtained by mag-
netic cell sorting (MACS; Miltenyi Biotec) using a
mouse anti-STRO-1 and a rabbit anti-c-Kit antibodies
(Abs; Santa Cruz). This hDPSCs population underwent a
further immune-selection by MACS technology using a
mouse anti-CD34 ab (Millipore), in order to separate the
STRO-1+/c-Kit+/CD34− and STRO-1+/c-Kit+/CD34+
fractions.FACS analysis
In order to assay the percentage of cells expressing
STRO-1, c-Kit and CD34 surface antigens, FACS ana-
lysis was performed on the whole unsorted hDPSCs after
in vitro expansion (~5 × 106 cells), at passage 1. Like-
wise, the percentage of cells triple labelled for STRO-1,
c-Kit and CD34 or double labelled for STRO-1, c-Kit
and negative for CD34 expression was evaluated.
Indirect staining was performed using mouse IgM
anti-STRO-1, rabbit IgG anti-c-Kit (Santa Cruz) and
mouse IgG anti-CD34 (Millipore), followed by goat anti-
mouse-IgM-Alexa488, donkey anti-rabbit-IgG-Alexa647,
and goat anti-mouse-IgG-Alexa405 (Invitrogen). Non-
specific fluorescence was assessed by using normal mouse
IgG or IgM followed by the secondary antibody as de-
scribed above. Cells were acquired using Attune acous-
tic flow cytometer (Life Technologies, Thermo Fischer
Scientific) equipped with four lasers (blue 488 nm, yellow
561 nm, red 638 nm and violet 405 nm). Data were ana-
lyzed using FlowJo 9.8 (Treestar, Miltenyi).
Cell proliferation
The proliferation rate was analyzed on both CD34− and
CD34+ hDPSCs populations, seeded at the density of 4 ×
103 cells/cm2 and cultured for 1 week until reaching the
confluence.
Each day cell counting was performed on both CD34−
and CD34+ hDPSCs. The mean of cell number was cal-
culated on three experimental samples for each experi-
mental group and cell density was expressed as mean of
cells/cm2 ± standard deviation (SD). The population
doubling time (PDT) was calculated in the phase of ex-
ponential growth by the following formula:
PDT¼ log10 2ð Þ ΔT
log10 N7dð Þ‐log10 N1dð Þ
N7d is the cell number at day 7 and N1d is the cell
number at day 1. Then, to determine the population
doubling (PD) rate, both CD34− and CD34+ hDPSCs
populations were initially seeded in culture medium at
the density of 4 × 103 cells/cm2. Cells were passaged and
counted once they reached a sub-confluence of 80%. At
each passage cell were re-plated at the initial density and
cultures were performed until passage 6. Three samples
for each experimental group were used. The following
formula was applied:
PD¼ log10 Nð Þ‐log10 Nsð Þ
log10 2ð Þ
N is the harvested cell number and Ns is the initial
plated cell number. Cumulative population doublings
(CPD) index for each passage was obtained by adding
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sages [47].
Cell senescence and apoptosis
In order to investigate cell senescence occurrence in
CD34− and CD34+ hDPSCs, cells at passage 6 were
seeded in 12-well plates and cultured upon confluence.
Samples were then processed by a senescence β-
galactosidase staining kit (Cell Signaling), according to
manufacturer’s instructions. Three samples for each
hDPSCs population were analyzed and the percentage of
senescent cells was calculated. The presence of apoptotic
cells in CD34− and CD34+ hDPSCs cultures was ana-
lyzed by detection of the active form of caspase 3. Whole
cell lysates of CD34− and CD34+ hDPSCs at passage 1
and 6 were processed for Western blot analysis and ac-
tive caspase 3 was detected by an anti-caspase 3 specific
ab (Cell Signaling). Densitometry of active caspase 3
bands was performed by NIS software (Nikon). An equal
area was selected inside each band and the mean of gray
levels (in a 0–256 scale) was calculated. Data, repre-
sented as integrated density (the sum of pixel values
minus a background value for each pixel within a
bounded area), were then normalized to values of back-
ground and of control actin band.
Surface antigens expression: confocal
immunofluorescence analysis
The expression of stemness surface antigens by hDPSCs
from both CD34− and CD34+ populations was assessed
at passage 1 and 6 through immunofluorescence label-
ling. Monolayer cells were fixed in 4% paraformaldehyde
in phosphate buffer saline (PBS) at pH 7.4 for 20 mi-
nutes, then after washing in PBS, cells were perme-
abilized with 0,1% Triton X-100 in PBS for 5 minutes;
samples were then blocked with 3% BSA in PBS for
30 minutes at room temperature and then incubated
with the primary antibodies diluted 1: 50 [mouse IgM
anti-STRO-1 (Santa Cruz), rabbit anti-c-Kit (Santa
Cruz), mouse anti-CD34 (Millipore)] in PBS containing
3% BSA, for 1 hour at room temperature. After washing
in PBS containing 3% BSA, the samples were incubated
for 1 hour at room temperature with the secondary anti-
bodies diluted 1:200 in PBS containing 3% BSA (goat
anti-mouse Alexa647; goat anti-rabbit Alexa488; donkey
anti-mouse Alexa546). After washing in PBS samples
were stained with 1 μg/ml DAPI in PBS for 1 minute, and
then mounted with anti-fading medium (FluoroMount,
Sigma Aldrich). Negative controls consisted of samples
not incubated with the primary ab. The multi-labelling im-
munofluorescence experiments were carried out avoiding
cross-reactions between primary and secondary abs. Con-
focal imaging was performed by a Nikon A1 confocal laser
scanning microscope as previously described [48,49]. Theconfocal serial sections were processed with ImageJ soft-
ware to obtain three-dimensional projections and image
rendering was performed by Adobe Photoshop Software.
Multilineage differentiation
The CD34− and CD34+ hDPSCs populations were also
evaluated for their multilineage differentiation potential,
namely they were induced towards osteogenic, myogenic,
adipogenic and neurogenic lineages. Three samples per
experimental group were used for each differentiation
experiment.
In order to obtain osteogenic differentiation CD34−
and CD34+ hDPSCs were seeded at approximately 3 ×
103 cells/cm2 on culture dishes in osteogenic medium
(culture medium supplemented with 5% FCS, 100 μM
2P-ascorbic acid, 100 nM dexamethasone, 10 mM β-
glycerophosphate). Double immunofluorescence stainings,
by using rabbit anti-Runx2 (Abcam) and mouse anti-
osteopontin (OPN; Santa Cruz) abs, rabbit anti-osterix
(Osx; GeneTex) and mouse anti-osteocalcin (OCN;
Abcam) abs, were performed to evaluate the expression
of bone specific proteins, four weeks after osteogenic
induction on both hDPSCs subpopulations. Moreover
deposition of mineralized extracellular matrix was
assessed through Alizarin Red staining.
Myogenic differentiation experiments were carried out
as formerly described by Pisciotta et al. [47]: the two
hDPSCs subpopulations were directly co-cultured with
C2C12 mouse myoblasts with a 10:1 seeding ratio, in
DMEM High Glucose, supplemented with 10% FCS,
2 mM L-glutamine, 100 U/ml penicillin, 100 mg/ml
streptomycin, until confluence was reached. Upon con-
fluence, growth medium was replaced by DMEM High
Glucose supplemented with 1% FCS and 10 nM insulin.
Cells were maintained in co-culture for 2 weeks. Direct
co-culture with C2C12 myoblasts was performed to
evaluate the myogenic potential of the two hDPSCs sub-
populations, since this practice represents an in vitro
model of myogenesis to test the ability of non-myogenic
cell types to fuse and form new myotubes [42,50].
Double immunofluorescence stainings, by using a
mouse anti-human mitochondrial protein ab (anti-hMit;
Millipore) or a mouse anti-human Nuclei ab (hNu;
Millipore) and a rabbit anti-myosin (Sigma Aldrich) ab,
were performed in order to verify the formation of myo-
tubes with the direct contribution of the two hDPSCs
subpopulations.
Adipogenic and neurogenic differentiation were per-
formed as previously described [47]. Adipogenic differ-
entiation: CD34− and CD34+ hDPSCs were seeded on
24-well plates at a cell density of 2 × 104 cells/cm2. Sub-
confluent cultures were incubated in the adipogenic
medium (culture medium medium containing 0.5 mM
isobutyl-methylxanthine, 1 μM dexamethasone, 10 μM
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for 3 weeks. Medium was changed every 3 days. After-
wards, cells were evaluated for the formation of lipid
droplets by means of oil red O staining and AdipoRed
assay (according to manufacturer’s instructions; Lonza).
Neurogenic differentiation: both the hDPSCs popula-
tions were seeded on 6-well plates at 2 × 104 cells/cm2
cell density. After confluency was reached, cells were
pre-induced with culture medium supplemented with
1 mM β-mercaptoethanol. After 24 hours, the cells were
washed in PBS and differentiated in serum free α-MEM
containing 10 mM β-mercaptoethanol, 2% dimethyl
sulfoxide and 200 μM butylated hydroxyanisole until
neuronal-like morphology was appreciable. Both
hDPSCs populations were assayed for the expression of
either neuronal specific markers, such as β-III-Tubulin,
MAP2, Neu-N synapsin, and of glial specific markers,
such as GFAP.
Expression of nestin and CD271
Nestin, a member of the intermediate filament proteins
family, is expressed in dividing cells during the early
stages of development in the central nervous system,
while the cell surface antigen CD271 is one of the two
receptor types for neurotrophins, a family of protein
growth factors that promote neuronal cells survival and
differentiation. The expression of these markers was
evaluated through immunofluorescence labelling with
mouse anti-nestin (Millipore) and mouse anti-CD271
(BioLegend) abs in both undifferentiated CD34− and
CD34+ hDPSCs subpopulations.
Histochemistry and western blot analysis
Three samples of in vitro differentiated CD34− and
CD34+ hDPSCs were fixed in 4% paraformaldehyde in
PBS at pH 7.4 for 20 minutes and were processed for
subsequent steps. For Alizarin red staining fixed cells
were incubated for 5 minutes at room temperature in a
solution containing 0.1% alizarin red and 1% ammonium
hydroxide. Images were collected by a CCD colour cam-
era equipped with a 90 mm macro photograph objective.
Densitometry was performed on culture plates from
three independent experiments by NIS software (Nikon).
An equal area (ROI) was selected around the plate surface
and the mean of gray levels (in a 0–256 scale) was calcu-
lated. Data were then normalized to values of background
and expressed as mean ± SD.
Whole cell lysates obtained from both hDPSCs popu-
lations, CD34− and CD34+, differentiated in osteogenic
medium, were processed for Western blot analysis as
previously described [48,49].
Thirty μg of protein extract from each sample were
separated by SDS-PAGE and then transferred to PVDF
membranes. The following abs were used: mouse anti-osteocalcin (OCN, Abcam); mouse anti-human Collagen
I (Millipore); rabbit anti-caspase 3 (Sigma Aldrich) and
rabbit anti-β-III-tubulin (Cell Signaling) diluted 1:1000;
HRP-conjugated anti-mouse and anti-rabbit secondary
ab (Pierce Antibodies, Thermo Scientific) diluted 1:3000.
The membranes were visualized by using Enhanced
Chemio Luminescence (ECL; Amersham). Anti-actin ab
was used as control of protein loading. Densitometry of
OCN and Collagen I was performed by NIS software
(Nikon). An equal area was selected inside each band
and the mean of gray levels (in a 0–256 scale) was calcu-
lated. Data were then normalized to values of back-
ground and of control actin band. List of antibodies
used and related dilutions were reported in Table 1.
Statistical analysis
All experiments were performed in triplicate. Data were
expressed as mean ± standard deviation (SD). Differ-
ences between the two experimental groups were ana-
lyzed by paired, Student’s t test. Differences among three
or more experimental samples were analyzed by
ANOVA followed by Newman-Keuls post-hoc test
(GraphPad Prism Software version 5 Inc., San Diego,
CA, USA). In any case, significance was set at p<0.05.
Results
FACS analysis
The expression of STRO-1, c-Kit and CD34 surface anti-
gens was assayed on unsorted hDPSCs after in vitro expan-
sion, at passage 1. Flow cytometry analysis revealed that
the unsorted hDPSCs showed the expression of the three
evaluated markers, specifically ~ 2.1% STRO-1, ~ 0.5%
c-Kit and ~ 1.5% CD34, respectively (Figure 1A).
Furthermore, flow cytometry analysis was performed
to evaluate the percentage of cells simultaneously posi-
tive for the three markers STRO-1/c-Kit/CD34 and cells
positive for STRO-1/c-Kit and negative for CD34. Data
showed that ~ 0.5% hDPSCs negative for CD34 co-
expressed STRO-1 and c-Kit, whereas ~ 20% of hDPSCs
positive for CD34 co-expressed STRO-1 and c-Kit
(Figure 1B).
Cell proliferation
In order to evaluate the growth kinetics of both CD34−
and CD34+ hDPSCs, proliferation rate was analyzed on
both the populations seeded in 60 mm Petri dishes at
the density of 4 × 103 cells/cm2 and cultured for 1 week
until reaching the confluence. Cell counting was per-
formed each day on 6 randomly selected fields of
1 mm2. Both the cell populations, CD34− and CD34+
hDPSCs demonstrated a parallel rising trend up to day
5, then, differences in growth kinetics of these two popu-
lations were observed; in particular, the CD34− hDPSCs
showed a consistent increase in proliferation upon day 8
Table 1 List of antibodies and related dilution used
Name Host Provider Dilution Application
anti-STRO-1 mouse Santa Cruz 1: 50 FACS, IF
anti-c-Kit rabbit Santa Cruz 1: 50 FACS, IF
anti-CD34 mouse Millipore 1: 50 FACS, IF
anti-Runx2 rabbit Abcam 1:100 IF
anti-osteopontin mouse Santa Cruz 1:100 IF
anti-osterix rabbit GeneTex 1:100 IF
anti-osteocalcin mouse Abcam 1:100; 1:1000 IF; WB
anti-human collagen I mouse Millipore 1:1000 WB
anti-human nuclei mouse Millipore 1:100 IF
anti-human mitochondrial protein mouse Millipore 1:100 IF
anti-myosin rabbit Sigma Aldrich 1:100 IF
anti-β-III-Tubulin rabbit Cell Signaling 1:100; 1:1000 IF; WB
anti-MAP2 mouse Sigma Aldrich 1:100; 1:1000 IF; WB
anti-NeuN mouse Millipore 1:100 IF
anti-Synapsin rabbit Cell Signaling 1:100 IF
anti-GFAP mouse Cell Signaling 1:100; 1:1000 IF; WB
anti-nestin mouse Millipore 1:100 IF
anti-CD271 mouse BioLegend 1:100 IF
anti-caspase 3 rabbit Sigma Aldrich 1:1000 WB
anti-actin goat Santa Cruz 1: 3000 WB
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dramatically slowed down from day 6 through day 8
(Figure 2A). As a matter of fact, the proliferation index
of CD34+ hDPSCs was significantly lower at days 7 and
8 when compared to the CD34− hDPSCs population
(Figure 2A). Statistically significant differences between
the two hDPSCs populations were highlighted by the
analysis of cumulative population doubling (CPD) which,
as early as at passage 2 (P2), resulted significantly lower
in CD34+ population compared to CD34− population, a
significant difference that was observed through the pas-
sages up to P5 (Figure 2B, left side). Data from CPD ana-
lysis demonstrated also that CD34- hDPSCs had a
steadily rising growth kinetics through all the passages,
whereas the CD34+ hDPSCs reached a growth peak at
P3, then slowed down at P4 up to P5 (Figure 2B, left
side). Furthermore, the population doubling time (PDT)
of CD34− hDPSCs was lower than CD34+ hDPSCs
(STRO-1+/c-Kit+/CD34− hDPSCs: 19.91± 2.30 hours;
STRO-1+/c-Kit+/CD34+ hDPSCs: 24.55  4.20 hours;
***p<0.001) (Figure 2B, right side).
Cell senescence, apoptosis and surface antigens
expression
Cell senescence, evaluated by detection of β-galactosidase
activity in confluent culture of CD34− and CD34+ hDPSCs
grown up to 5 passages, revealed very low levels of β-galactosidase in CD34− population, whereas a significant
percentage of senescent cells was revealed in CD34+ popu-
lation by microscopic observation (Figure 3A; <2% STRO-1
+/c-Kit+/CD34− hDPSCs vs ≈ 90% STRO-1+/c-Kit+/CD34+
hDPSCs positive to β-galactosidase assay).
Moreover, western blot analysis of active caspase 3
was carried out on whole cell lysates from CD34− and
CD34+ hDPSCs at passage 1 and 6 to evaluate whether
apoptosis occurred at late passage (Figure 3B, top). A sig-
nificant amount (p<0.001) of the active form of caspase 3
(17 kDa) was expressed by CD34+ hDPSCs obtained at
passage 6, conversely no significant expression of caspase
3 could be detected in CD34− hDPSCs, as shown by densi-
tometric analysis (Figure 3B, bottom).
Human DPSCs from both the CD34− and CD34+ pop-
ulations were obtained at passage 1 and 6 and evaluated
through immunofluorescence labeling for the expression
of the markers they were immune-selected for. While
the expression of the above mentioned antigens was pre-
served by the CD34− subpopulation either at passage 1
and passage 6, a reduction in the expression of all the
three antigens was observed in the CD34+ subpopula-
tion, as early as at passage 6 (Figure 3C). Moreover, the
presence of pyknotic nuclei, which denotes a degenera-
tive process of cell nucleus, occurring in apoptosis and
necrosis, with the nucleus showing a reduction in vol-
ume and becoming more intensely stained, was observed
Figure 1 Cytofluorimetric analysis of STRO-1, c-Kit and CD34 expression in whole unsorted hDPSCs. A: Unsorted hDPSCs were plotted
SSC vs. STRO-1, c-Kit and CD34 at day 7after isolation and expansion in vitro. B: unsorted hDPSCs were gated on CD34, then the plot STRO-1
vs c-Kit was done in CD34+ and CD34- cells.
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asterisks).Multilineage differentiation
Human DPSCs from both CD34− and CD34+ subpopu-
lations were differentiated towards osteogenic, myogenic,adipogenic and neurogenic lineages, as described in ma-
terials and methods section.
After 4 weeks of osteogenic induction in both CD34−
and CD34+ hDPSCs cultures confocal analysis revealed
the expression of osteocalcin (OCN), together with other
specific markers of osteogenic commitment, such as
osterix (Osx) and osteopontin (OPN) (Figure 4A).
Figure 2 Evaluation of cell proliferation in STRO-1+/c-Kit+/CD34− hDPSCs and STRO-1+/c-Kit+/CD34+ hDPSCs. A: Proliferation rate of
STRO-1+/c-Kit+/CD34− hDPSCs and STRO-1+/c-Kit+/CD34+ hDPSCs cultured for 1 week. Values, expressed as mean ± SD, are reported in a Log
scale, n = 3; *indicates values of unpaired t-test STRO-1+/c-Kit+/CD34+ hDPSCs vs STRO-1+/c-Kit+/CD34− hDPSCs (***p<0,001). B: Left side:
cumulative population doubling (CPD) of STRO-1+/c-Kit+/CD34− hDPSCs and STRO-1+/c-Kit+/CD34+ hDPSCs cultured for a total of 5 passages
(n = 3; ***p<0,001). Right side: population doubling time (PDT) of STRO-1+/c-Kit+/CD34− hDPSCs and STRO-1+/c-Kit+/CD34+ hDPSCs was
calculated in log phase. Values are reported as mean ± SD; *indicates values of unpaired t-test STRO-1+/c-Kit+/CD34+ hDPSCs vs STRO-1+/c-Kit
+/CD34− hDPSCs (***p<0,001).
Pisciotta et al. BMC Developmental Biology  (2015) 15:14 Page 8 of 16Double immunofluorescence labeling was aimed to sim-
ultaneously analyze the localization of OCN/Osx and
OPN/OCN in both hDPSCs populations (Figure 4A).
Signal from OCN, which appeared typically localized in
the cytoplasm, was also detected in extracellular matrix,
where it was present as spots corresponding to
mineralization areas. Conversely, Osx showed a peculiar
nucleoplasmic localization. No significant differences
were observed between the two hDPSCs subpopulations.
Mineralization of the extracellular matrix, detected
through Alizarin Red staining, was clearly evident in
both CD34− and CD34+ subpopulations (Figure 4B); nosignificant differences were observed between the two
experimental groups. A further confirmation that both
CD34− and CD34+ hDPSCs achieved the osteogenic
commitment was provided by the expression of OCN
and type I collagen (Coll-I) through western blot analysis
on whole cell lysates of differentiated hDPSCs. No sig-
nificant differences between the two populations were
detected by densitometry.
The ability of CD34− and CD34+ hDPSCs to differentiate
towards myogenic lineage was assessed by direct co-culture
with C2C12 mouse myoblasts. After 2 weeks of co-culture
myotubes formation was observed in co-cultures with
Figure 3 Cell senescence, apoptosis and surface antigens expression
in STRO-1+/CD34− hDPSCs and STRO-1+/c-Kit+/CD34+ hDPSCs. A:
β-Galactosidase activity staining in confluent cultures of STRO-1+/
c-Kit+/CD34- hDPSCs and STRO-1+/c-Kit+/CD34+ hDPSCs grown for
5 passages. Blue labeling indicates cells positive to β-galactosidase
activity staining. Bar: 50 μm. B: Western blot analysis of active caspase 3
expression by STRO-1+/c-Kit+/CD34− hDPSCs and STRO-1+/c-Kit+/CD34+
hDPSCs at passages 1 and 6. Blasts treated with etoposide were loaded
as positive control of the presence of active caspase 3. Actin bands
were presented as control of the protein loading. Densitometry of
caspase 3 bands was shown at the bottom of western blot images.
[***p<0,001 DPSC STRO-1+/c-Kit+/CD34+ (P6) vs DPSC STRO-1+/
c-Kit+/CD34+ (P1), unpaired t-test; n=3]. C: Immunofluorescence
labeling shows signals from c-Kit (red), STRO-1 (blue) and CD34
(green) in both the subpopulations of hDPSCs, analyzed at passages
1 and 6. DAPI staining is shown in grey. Yellow asterisks indicate the
presence of pyknotic nuclei. Bar: 10 μm.
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CD34+ subpopulations. Myotubes appeared multinucleated
indicating that cell fusion occurred. Labeling by anti-
human mitochondria antibody (anti-hMit) demonstrated
that both hDPSCs subpopulations were involved in
myotubes generation. The expression of myosin by
newly formed myotubes indicated that a terminal myo-
genic commitment was reached (Figure 5A). Double
immunofluorescence staining with anti-human nuclei
(hNu) and anti-myosin antibodies demonstrated that in
both culture conditions mature myotubes were formed
with the contribution of hDPSCs. Myotubes not labeled
by anti-hMit/hNu antibody and therefore formed only
by C2C12 cells were also present (Figure 5A).
For adipogenic differentiation CD34− and CD34+
hDPSCs started to form lipid droplets after 10 days of
induction. After 3 weeks of differentiation, lipid droplets
formation was evaluated either by oil red O staining and
AdipoRed assay (Figure 5B). Oil red O staining revealed
by microscopic observation the formation of lipid droplets
by both CD34− and CD34+ hDPSC populations (Figure 5B,
top). AdipoRed assay was performed in order to confirm
the data from microscopic observation; as AdipoRed bind-
ing to triglycerides contained within intracellular lipid rich
vacuoles leads to fluorescence emission, both hDPSCs
subpopulations were evaluated for lipid droplets formation
by confocal microscopy analysis, showing a fluorescent
staining (Figure 5B, middle). Also, quantification of triglyc-
erides - expressed as relative fluorescent unit (RFU) - car-
ried out by fluorimeter analysis confirmed the adipogenic
commitment of both CD34− and CD34+ hDPSCs popula-
tions (STRO-1+/c-Kit+/CD34− hDPSCs: 971.9 ± 61.0 RFU;
STRO-1+/c-Kit+/CD34+ hDPSCs: 984.0 ± 72.7 RFU). No
differences were observed between the two experimental
groups (Figure 5B, bottom).
Neurogenic differentiation started with a first cell de-
tachment from culture plates, event that may be likely
induced by β-mercaptoethanol. Cells still adhering
Figure 4 Evaluation of osteogenic differentiation of STRO-1+/c-Kit
+/CD34− hDPSCs and STRO-1+/c-Kit+/CD34+ hDPSCs. A: Confocal
analysis of osteogenic differentiation of STRO-1+/c-Kit+/CD34− hDPSCs
and STRO-1+/c-Kit+/CD34+ hDPSCs. Double immunofluorescence
confocal images showing signals from anti-OPN (red), anti-OCN
(green) and DAPI (blue), and from anti-OCN (green) and anti-Osx
(red), respectively. Bar: 10 μm. B: Alizarin Red staining on STRO-1+/c-Kit
+/CD34− hDPSCs and STRO-1+/c-Kit+/CD34+ hDPSCs. Densitometric
analysis show the deposition of extracellular mineralized matrix by both
the subpopulations after the osteogenic induction. Values are mean ±
SD of gray levels (0–255 scale). STRO-1+/c-Kit+/CD34− hDPSCs n = 3;
STRO-1+/c-Kit+/CD34+ hDPSCs n = 3; *** p<0,001 STRO-1+/c-Kit+/CD34
− hDPSCs and STRO-1+/c-Kit+/CD34+ hDPSCs vs undifferentiated
hDPSCs, ANOVA test followed by Newman-Keuls post-hoc test.
C: Western blot (WB) analysis of Coll-I and OCN expression in
whole cell lysates of differentiated STRO-1+/c-Kit+/CD34− hDPSCs
and STRO-1+/c-Kit+/CD34+ hDPSCs. Whole cell lysates were
collected from three plates of hDPSCs for each experimental group.
Fibroblasts were used as positive controls for Coll-I expression and as
negative controls for osteocalcin expression, respectively. Actin
bands demonstrate that an equal amount of protein was loaded in
each line. Densitometric analysis of the bands corresponding to
Coll-I and OCN is shown below western blot images. Values are
mean ± SD of gray levels (0–255 scale); ***p<0,001 diff STRO-1+/c-
Kit+/CD34− hDPSCs vs undiff STRO-1+/c-Kit+/CD34−, §§§p<0,001 diff
STRO-1+/c-Kit+/CD34+ hDPSCs vs undiff STRO-1+/c-Kit+/CD34+
hDPSCs, ANOVA test followed by Newman-Keuls post-hoc test.
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multiple cellular processes and a defined cell body. After
1 week of induction a strong response was observed in
CD34+ hDPSCs which showed a greater expression of β-
III-Tubulin, compared to CD34− hDPSCs, which dem-
onstrated to be induced only to a lesser extent towards
the neurogenic commitment (Figure 6A). Moreover, the
expression of further neuronal specific markers was in-
vestigated, showing that CD34+ hDPSCs were labeled by
anti-MAP2, anti-Neu-N and anti-synapsin antibodies,
confirming the occurrence of neuronal differentiation.
Figure 6A shows that CD34+ hDPSCs positive for neur-
onal marker (β-III-Tubulin) are distributed close to glial
cells positively stained by GFAP marker. These results
were confirmed by western blot analysis highlighting
a difference between the two experimental groups
(Figure 6B).
Expression of nestin and CD271
Immunofluorescence analysis was carried out on undif-
ferentiated CD34− and CD34+ hDPSCs in order to
evaluate the expression of nestin and CD271, which are
involved in the early development of central nervous
system and in promotion of survival and differentiation
of neuronal cells besides identifying the neural crest de-
rived cells. A clear difference between the two subpopu-
lations was observed, as the CD34− hDPSCs did not
express any of these markers, while CD34+ hDPSC
Figure 5 (See legend on next page.)
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Figure 5 Evaluation of myogenic differentiation and adipogenic differentiation in STRO-1+/c-Kit+/CD34− hDPSCs and STRO-1+/c-Kit+/CD34+
hDPSCs. A: Confocal analysis of myogenic differentiation of STRO-1+/c-Kit+/CD34− hDPSCs and STRO-1+/c-Kit+/CD34+ hDPSCs directly co-
cultured with C2C12 mouse myoblasts. Double immunofluorescence labeling shows signals from anti-hMit (green) and anti-myosin (red) and
from anti-hNu (green) and anti-myosin (red), respectively. DAPI staining is shown in blue. Bar: 10 μm. B: Evaluation of adipogenic commitment in
STRO-1+/c-Kit+/CD34− hDPSCs and STRO-1+/c-Kit+/CD34+ hDPSCs. On the top, histological staining with Oil Red O showing adipogenic differentiation
of STRO-1+/c-Kit+/CD34− hDPSCs and STRO-1+/c-Kit+/CD34+ hDPSCs. Cells were counterstained with haematoxylin. Bar: 10 μm. Below, AdipoRed assay
performed on both hDPSCs subpopulations, evaluated for lipid droplets formation by confocal microscopy analysis. Differentiated STRO-1+/c-Kit+/CD34−
hDPSCs and STRO-1+/c-Kit+/CD34+ hDPSCs show a green fluorescent staining. Bar: 10 μm. At the bottom, quantification of triglycerides (RFU, relative
fluorescent unit) carried out by fluorimeter analysis. ***p<0,001 diff STRO-1+/c-Kit+/CD34− hDPSCs vs undiff STRO-1+/c-Kit+/CD34− hDPSCs; §§§p<0,001 diff
STRO-1+/c-Kit+/CD34+ hDPSCs vs undiff STRO-1+/c-Kit+/CD34+ hDPSCs, ANOVA test followed by Newman-Keuls post-hoc test.
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CD271 (Figure 7).Discussion
Mesenchymal cells derived from neural crest are respon-
sible for the construction of craniofacial skeleton during
embryo and tooth-periodontium formation over fetal and
adult life [51]. These cells are involved in the development
of several, although distinct, hard tissues, including crown
and root dentin, cementum, and alveolar bone. So far, ac-
cording to their common origin, it has not been feasible to
identify a specific marker for differentiated cells of each of
these structures.
Furthermore, neural crest-derived stem cells are also
present within the adult human body, enclosed within
the dental pulp, which hence represents a source of stro-
mal stem cells [9], contained in an ideal niche, i.e. the
pulp chamber. Many are the sources from which dental
stem cells can be retrieved, such as human permanent
teeth (DPSCs), exfoliated deciduous teeth (SHEDs), ap-
ical papilla of immature permanent teeth (SCAPs),
periodontal ligament (PDLSCs) and dental follicle
(DFPCs) [9-16].
Several different mesenchymal stem cell markers were
used to select distinct subsets of DPSCs, exhibiting dif-
ferent biological behaviors [18]. Among several surface
antigens, three specific stem cell markers were analyzed;
STRO-1, considered an early marker of mesenchymal
stem cells [52-54], identifies a cell surface antigen
expressed by the osteogenic fraction of stromal precur-
sors in human bone marrow as well as in erythroid pre-
cursors [52,53,55,56]. Other data have suggested that
STRO-1 recognizes also a stromal cell precursor of peri-
cyte cells in dental pulp [57]. Another marker for stem
cells, c-Kit, which has been already used for stem cells
[58-60], was highly and early expressed in dental pulp
stem cells. Interestingly, c-Kit is clearly expressed in
neural crest-derived cells, like melanocyte precursors
[21] and cells deriving from neural crest progenitors, like
dental pulp. Furthermore, CD34, another marker associ-
ated to primitive pluripotent stem cells both stromal and
hematopoietic [37], has been analyzed.Notably, increasing evidence has been demonstrating
CD34 expression by several cell types, including multipo-
tent mesenchymal stromal cells [61], although a miscon-
ception persists that CD34 distinctively represents cells of
hematopoietic origin. Given these considerations, a huge
interest has been aroused towards the investigation of
CD34 expression and role in a specific subpopulation of
hDPSCs.
Our data demonstrated that a low percentage of un-
sorted hDPSCs was positive for the expression of all the
three markers. Based on these preliminary considerations,
the aim of this study was to analyze and compare the
characteristics of two subpopulations of hDPSCs. Starting
from a first positive immune-selection for STRO-1 and c-
Kit surface antigens, the sorted STRO-1+/c-Kit+ hDPSCs
underwent a further immune-selection for CD34, in order
to separate and compare the STRO-1+/c-Kit+/CD34− and
STRO-1+/c-Kit+/CD34+ subpopulations, in terms of pro-
liferation capacity, stemness maintenance, senescence,
apoptosis, and multi-lineage differentiation potential.
From these investigations it was found that STRO-1+/c-
Kit+/CD34− hDPSCs and STRO-1+/c-Kit+/CD34+ hDPSCs
actually are two different cell populations showing distinct
behaviors.
Data from the analysis of cell proliferation, with par-
ticular regard to CPD and PDT values, demonstrated
that STRO-1+/c-Kit+/CD34− hDPSCs show either a
higher proliferation capacity and a lower doubling time,
compared to STRO-1+/c-Kit+/CD34+ hDPSCs; indeed
the latter exhibited, as early as at day 5, a slowdown in
proliferation kinetics and, contrary to STRO-1+/c-Kit
+/CD34− hDPSCs, showed a reduction in cell density
over the culture time. Further analyses highlighted an
appreciable cell suffering in STRO-1+/c-Kit+/CD34+
hDPSCs, which resulted early induced towards cell senes-
cence, as revealed by the high number of cells positively
labeled through the β-galactosidase assay; moreover cell
apoptosis could be detected as early as at passage 6,
another event that was not observed in STRO-1+/c-Kit
+/CD34− hDPSCs subpopulation. Still at passage 6, the
expression of the stem cell markers used to immune-
select the two subpopulations was evaluated, showing
that STRO-1+/c-Kit+/CD34− hDPSCs were actively
Figure 6 Neurogenic differentiation of STRO-1+/c-Kit+/CD34−
hDPSCs and STRO-1+/c-Kit+/CD34+ hDPSCs. A: Confocal
analysis of neurogenic differentiation of STRO-1+/c-Kit+/CD34−
hDPSCs and STRO-1+/c-Kit+/CD34+ hDPSCs after 1 week of induction.
Immunofluorescent staining show differentiated STRO-1+/c-Kit+/CD34-
hDPSCs and STRO-1+/c-Kit+/CD34+ hDPSCs expressing β-III-Tubulin,
MAP2, NeuN, Synapsin and GFAP. Bar: 10 μm. B: Western blot (WB)
analysis of β-III-Tubulin, MAP2 and GFAP expression in whole cell lysates
of differentiated STRO-1+/c-Kit+/CD34− hDPSCs and STRO-1+/c-Kit
+/CD34+ hDPSCs. Actin bands were used as control of protein loading.
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stemness markers. Conversely, in STRO-1+/c-Kit
+/CD34+ hDPSCs, the expression of CD34 was com-
pletely lost, while STRO-1 and c-Kit expression was
maintained.
These data are in accordance with findings reviewed
by Lin et al. [61] showing that after in vitro expansion
and cell culturing a loss of CD34 expression was ob-
served also in bone marrow mesenchymal stem cells
[62]. Moreover, the culture conditions themselves might
be the basis of the differences highlighted in CPD and
PDT values and of the loss of CD34 expression.
Although the function of CD34 surface marker is still
unknown, it has been related to facilitation or inhibition
of adhesion, cell proliferation and regulation of differen-
tiation [63,64]. Particularly, as reported by Sidney et al.
[65], cell culture on plastic surface in serum-containing
medium could create an environment dissimilar to theFigure 7 Expression of nestin and CD271 by undifferentiated
hDPSCs subpopulations. Confocal analysis of the expression of neural
markers, nestin and CD271, by undifferentiated STRO-1+/c-Kit+/CD34−
hDPSCs and STRO-1+/c-Kit+/CD34+ hDPSCs. Immunofluorescence
labeling shows signals from nestin (green) and CD271 (green),
respectively. DAPI staining is shown in blue. Bar: 10 μm.
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sive arrest of proliferation and senescence.
Relevant data regarding these two subpopulations were
also provided by the evaluation of their differentiation
potential in vitro, following the use of equal culture
conditions.
No significant differences have emerged from the in-
duction towards the osteogenic, adipogenic and myo-
genic lineages, in fact, the two subpopulations showed
similar abilities in the expression of lineage specific
markers. With regard to the osteogenic differentiation,
both STRO-1+/c-Kit+/CD34− hDPSCs and STRO-1+/c-
Kit+/CD34+ hDPSCs, after the induction, showed the
expression of bone related proteins, such as osteocalcin,
osteopontin, osterix and type I collagen, besides an
active deposition of mineralized extracellular matrix.
The induction towards the adipogenic commitment
produced the formation of lipid rich vacuoles by both
the two subpopulations.
After the direct co-culture and differentiation together
with C2C12 mouse myoblasts either STRO-1+/c-Kit
+/CD34− hDPSCs and STRO-1+/c-Kit+/CD34+ hDPSCs
demonstrated the capability to actively participate in
new mature myotubes formation; in particular, the newly
formed myotubes were clearly hybrid and therefore de-
rived by the fusion of human stem cells with mouse myo-
blasts, as confirmed by the positive staining with
antibodies specific for mitochondrial and human proteins,
respectively. In particular, the newly formed myotubes
were hybrid and, therefore, derived by the fusion of both
human stem cells and mouse myoblasts, as confirmed by
the labeling with antibodies specific for human mitochon-
drial protein and human nuclei, respectively.
A notable difference between the two subpopulations
emerged from the evaluation of the induction towards the
neurogenic commitment. Interestingly, STRO-1+/c-Kit
+/CD34− hDPSCs showed a much lower efficiency of com-
mitment compared to STRO-1+/c-Kit+/CD34+ hDPSCs,
as demonstrated by β-III tubulin expression (2% vs 85%
positive cells, respectively) and by the shift to a neuronal-
like shape, following the induction.
In particular, STRO-1+/c-Kit+/CD34+ hDPSCs also
showed the expression of further markers, such as MAP-
2, Neu-N and synapsin, confirming a substantial commit-
ment towards neuronal lineage. The neurogenic induction
was also able to induce the differentiation towards glial-
like cells, as shown by the staining against GFAP. Overall,
the analysis of these two subpopulations would suggest
that a different embryological derivation exists, which
would allow to distinguish the STRO-1+/c-Kit+/CD34−
hDPSCs, derived from mesoderm layer, and the STRO-1
+/c-Kit+/CD34+ hDPSCs, whose origin might be traced
back to the ecto-mesoderm and therefore due to neural
crest cells migrating during the embryo development.In support of this hypothesis, the expression of two
specific markers, nestin and CD271, was evaluated in
both STRO-1+/c-Kit+/CD34− hDPSCs and STRO-1+/c-
Kit+/CD34+ hDPSCs.
Nestin, a component of the intermediate filament pro-
teins which form the cytoskeleton, is mostly expressed
by neuronal stem cells [66]; the surface antigen CD271
is one of the two receptors for neurotrophins, growth
factors that promote neuronal cells survival, besides be-
ing a marker that identifies neural crest derived cells.
The evaluation of the expression of these two markers
in both STRO-1+/c-Kit+/CD34− hDPSCs and STRO-1
+/c-Kit+/CD34+ hDPSCs after standard culture condi-
tions, without any induction towards the differentiation,
revealed that STRO-1+/c-Kit+/CD34− hDPSCs did not
show any expression of nestin and CD271, whereas the
STRO-1+/c-Kit+/CD34+ hDPSCs demonstrated a strong
expression of both the markers.
These further data support findings from Laino and
colleagues who formerly demonstrated that combined
expression of STRO-1, c-Kit and CD34 by hDPSCs
allowed to isolate a subpopulation of mesenchymal stem
cells of neural crest origin [42]. Notably, as reported in
literature, a few neural crest cells are known to be pluri-
potent, with self-renewal ability following migration,
which are features of stem cells, thus termed “neural
crest stem cells” (NCSCs). NCSCs have been isolated
from different adult tissues and can differentiate towards
mesenchymal lineage and neural lineage in vitro. It is
noteworthy that our latter results are in accordance with
findings from Abe and colleagues, reporting that sphere-
forming cells derived from stem cells of apical pulp tissue
express either NCSCs marker CD271 and neuronal stem
cell marker nestin, and are also able to undergo neuronal
differentiation [33].
Farther, in a previous study by Lizier and colleagues,
dental pulp was demonstrated to have multiple stem cell
niches, which are localized in capillaries and nerve net-
works in “cell free zone”, within the innermost pulp
layer in “cell rich zone”, and in the outermost layer con-
taining odontoblasts, being all these niches rich of nestin
positive cells [67]. According to previous findings it is
remarkable that STRO-1 antigen also recognizes a small
fraction of CD34+ stem cells [37,20], and that is localized
in large blood vessels of different adult tissues [35], in-
cluding dental pulp [57]. In light of these considerations,
our findings allow to infer that STRO-1+/c-Kit+/CD34+
hDPSCs reside in a perivascular niche, besides represent-
ing a stem cell population of neural crest origin.
The results obtained in this study highlight the hetero-
geneity of the stem population residing within the hu-
man dental pulp, particularly, its peculiar embryological
origin, might explain the existence of two distinct
subpopulations.
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The results obtained in our study are consistent with
previous reports from Laino et al. [20,42], in which
DPSCs positively sorted for the markers STRO-1, c-Kit
and CD34, were shown to be capable to differentiate
towards osteogenic, adipogenic and myogenic lineages,
although they can be also differentiated toward further
cytotypes. For these reasons, we have used the simultan-
eous expression of CD34, STRO-1 and c-Kit to isolate a
population of mesenchymal stem cells of neural crest
origin, thus confirming that neural crest-derived stem
cells are also present within the adult body, entrapped
within dental pulp [9]. In conclusion, although these re-
sults are promising, further investigations are required
in order to define the flexibility of application of hDPSCs
in regenerative medicine. Moreover, to fully characterize
a population of stem cells it is most likely that a specific
marker profile would be required, alongside differenti-
ation assays and functional profiling.
Likewise, if culture and propagation techniques for
STRO-1+/c-Kit+/CD34+ hDPSCs can be optimized in
order to obtain a sufficient number of cells combined to
a reduction of PDT, these cells might represent a source
of progenitor cells that can be exploited clinically in re-
generative medicine strategies.Ethical approval
No ethical approval by University Research Ethics
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